RL40 Challenges and Solutions in Designing of CNS Trials
*David Jianjun Li, Wyeth 


"CNS trial has its own challenges. A confirmatory phase III trial likely overthrows what you have believed and a decent dose-response phase II trial may not present a hint at all on trend. Let us face the merciless facts like these in CNS trials and discuss what we can do.